← Eichor
Study identifier: NCT05581368 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Studying the Effects of Cannabis on Vasculature

Condition: Cardiovascular Diseases · Inflammation · Atherosclerosis  ·  Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

PhaseN/A
Planned participants100
Who can joinAll sexes, 19 Years to 80 Years
Healthy volunteersYes

About this study

Cannabis is commonly used globally. It is associated with psychiatric problems, but the effects on the cardiovascular system are unclear. In this project, the investigators plan to study the effects of cannabis on the cardiovascular system. This will be done by using a non-invasive test to measure blood vessel function and by using blood samples to measure inflammation. As a control for this project, the investigators would like to test the blood vessel function and inflammation levels of participants who do not use cannabis. This study will provide important information on the long term cardiovascular effects of cannabis.

This description comes directly from the study's public registry record.

Talk to the study team

Mark Chandy, MD, PhD  ·  5196612111  ·  mark.chandy@lhsc.on.ca

Kerry-Ann Nakreiko, PhD  ·  5196612111  ·  Kerry-Ann.Nakrieko@lhsc.on.ca

Always discuss trial participation with your own doctor first.

Locations (1)

London Regional Health Science CentreLondon, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05581368